Cleft lip, which results from impaired facial process growth and fusion, is one of the most common cranio facial birth defects. Many genes are known to be involved in the etiology of this disorder; however, our under standing of cleft lip pathogenesis remains incomplete. In the present study, we uncovered a role for sonic hedgehog (SHH) signaling during lip fusion. Mice carrying compound mutations in hedgehog acyltransferase (Hhat) and patched1 (Ptch1) exhibited perturbations in the SHH gradient during frontonasal development, which led to hypoplastic nasal process outgrowth, epithelial seam persistence, and cleft lip. Further investi gation revealed that enhanced SHH signaling restricts canonical WNT signaling in the lambdoidal region by promoting expression of genes encoding WNT inhibitors. Moreover, reduction of canonical WNT signaling perturbed p63/interferon regulatory factor 6 (p63/IRF6) signaling, resulting in increased proliferation and decreased cell death, which was followed by persistence of the epithelial seam and cleft lip. Consistent with our results, mutations in genes that disrupt SHH and WNT signaling have been identified in both mice and humans with cleft lip. Collectively, our data illustrate that altered SHH signaling contributes to the etiology and pathogenesis of cleft lip through antagonistic interactions with other gene regulatory networks, including the canonical WNT and p63/IRF6 signaling pathways.
In contrast, PTCH1 is a receptor for HH ligands and works as a repressor of SHH signaling in the absence of SHH ligand. Consistent with this role, disruption of Ptch1 in mice results in an elevation of SHH signaling (22) . Through an N-ethyl-N-nitrosourea mutagenesis screen in mice (19) , we generated a novel allele of Ptch1. Genome sequencing revealed a T to A nucleotide change in intron 15 of Ptch1, which created a new splice acceptor site, resulting in a premature stop codon in exon 16 and generation of a truncated protein. Ptch1 wiggable embryos die in utero at around E12.0 as a result of various defects, including open neural tube and hypertelorism of the face (19) . These phenotypes are consistent with a gain of function in HH signaling. In an effort to mutually rescue the Hhat creface and Ptch1 wiggable phenotypes, we crossed Hhat creface mice with Ptch1 wiggable mice to generate double homozygotes (Hhat creface Ptch1 wiggable mice) and partially restored head morphology and craniofacial structures. Interestingly, however, these embryos presented with cleft lip ( Figure 1B ) and fissure of the premaxilla bone at E16.5 ( Figure 1E ), implying that HHAT and PTCH1 played an important role in regulating HH signaling during lip development.
MNPs and LNPs fail to fuse in Hhat creface Ptch1 wiggable embryos. To investigate the mechanism underlying the pathogenesis of cleft lip in Hhat creface Ptch1 wiggable mice, we explored the onset of developmental anomalies in individual and compound mutants (Figure 2 ). At E10.0, Ptch1 wiggable embryos showed severe craniofacial defects, including open neural tube, together with frontonasal and branchial arch anomalies ( Figure 2C ). Hhat creface embryos displayed a hypoplastic first branchial arch and minor frontonasal process (FNP) deformities ( Figure 2D ). Hhat creface Ptch1 wiggable embryos similarly presented with a smaller FNP ( Figure 2B ) compared with that of control embryos ( Figure 2A ). By E11.0, wild-type embryos exhibited prominent MNPs and LNPs ( Figure 2E ). In contrast, Ptch1 wiggable embryos displayed enlarged maxillary processes, but neither the MNPs nor LNPs could be readily distinguished at this stage (Figure 2G) . Hhat creface embryos showed facial deformities represented by reduced spacing between the bilateral nasal slits with hypoplastic maxillary and mandibular processes ( Figure 2H ). Hhat creface Ptch1 wiggable embryos showed a substantial restoration of facial development compared with each single mutant; however, these double mutants still displayed deficient MNP and LNP growth ( Figure 2F ). By E11.5, the MNP and LNP fused at the lambdoidal region in control embryos to form the future lip and primary palate ( Figure 2 , I, M, and Q). In contrast, Ptch1 wiggable embryos displayed severe defects in nasal process growth as well as nasal epithelium invagination ( Hhat creface Ptch1 wiggable embryos showed considerable outgrowth of the MNPs and LNPs compared with that at earlier stages; however, the failure of these processes to fuse left a large gap that leads to cleft lip and primary cleft palate (Figure 2 , J, N, and R).
Altered balance of cell proliferation and cell death in the nasal processes of Hhat creface Ptch1 wiggable embryos leads to failure of epithelial seam removal. Epithelial cell removal via cell death is a crucial event during facial process fusion (2) . In the case of normal development, epithelial seam cells between the FNP and MNP break down via loss of e-cadherin (ECAD) expression and apoptosis, as shown by TUNEL staining, which resulted in formation of a mesenchymal bridge ( Figure 3 , A-C, white arrow). Epithelial seam cell death usually occurs just at the tip of the fusing processes, which is similar to the process underlying secondary palate fusion. Hhat creface Ptch1 wiggable embryos exhibited reduced apoptosis in the seam where epithelial cell break down should normally occur ( Figure 3F , white arrow). Together with the persistence of ECAD-positive cells, this lead to the failure to form a mesenchymal bridge (Figure 3 , D-F, white arrow). Conversely, we found very few mitotic cells in the epithelial seam in control embryos, as measured by phospho-histone H3 immunostaining (Figure 3 , G-I and O). However, there was a considerable increase in phospho-histone H3-labeled cells in Hhat creface Ptch1 wiggable embryos (Figure 3 , J-L, yellow arrowheads, and O). These results suggest that during normal development epithelial seam cells stop proliferating and undergo apoptosis in order to break down epithelial cells as part of the mechanism of lip fusion. In contrast, the ECAD-positive epithelial cell layer ( Figure 3 , J-L) was thicker in Hhat creface Ptch1 wiggable embryos than in control embryos ( Figure 3 , G-I). We also assessed the persistence of periderm cells using an antibody that recognizes SSEA1 protein. Interestingly, the intensity of SSEA1 was stronger in the nasal process epithelia of Hhat creface Ptch1 wiggable embryos (Supplemental Figure 2 , B and D) compared with that of control embryos (Supplemental Figure 2, A and C) . These results suggest a persistence of periderm cells in the nasal processes of Hhat creface Ptch1 wiggable embryos in association with the failure of lip fusion.
The gradient of SHH signaling during facial morphogenesis was perturbed in each mutant. Since HHAT and PTCH1 are the key regulators of SHH signaling (18, 21, 22) , we hypothesized that each mutant should have altered SHH signaling during facial morphogenesis. Hence, we assessed Shh mRNA expression via in situ hybridization in developing E9.5 embryos. Regardless of the genotype, each embryo showed strong Shh mRNA expression in the notochord and floor plate (Figure 4 , A-D). We also observed that there was no Shh mRNA activity in the MNPs and LNPs among all the embryos at E11.0 (Figure 4 , E-H). We next performed Ptch1 and Gli1 in situ hybridization to document the degree of spatial perturbation of SHH signaling, since the activity of these genes is widely considered as representative of the gradient and range of SHH signaling. In control embryos, Ptch1 as well as Gli1 mRNA were expressed inten- Figure 3 , B and C), which is consistent with a diminished range and gradient of SHH signaling (18) . Craniofacial structures are partially restored in Hhat creface Ptch1 wiggable double-homozygous embryos, and, consistent with this, the quantity of Ptch1 and Gli1 mRNA in the maxillary complex was returned to normal, as assessed by RNA-seq (Supplemental Figure 3 , B and C). However, most importantly, the distribution of gene activity in Hhat creface Ptch1 wiggable embryos was not fully restored to a wild-type pattern, as ectopic expression remained in the LNP (Figure 4, J and N) .
Complementary SHH and canonical WNT signaling during craniofacial development. To investigate the gene regulatory network governing the cleft lip phenotype observed in double-mutant embryos, we performed RNA-seq analyses and identified a downregulation of canonical WNT signaling (Supplemental Figure 3 , G-I) in association with enhanced SHH signaling (Supplemental Figure 3 , B and C). We also discovered that cells that respond to canonical WNT signaling localize in complementary domains to SHH-responding cells in developing FNPs, as observed through LacZ reporter expression in TOPgal (23) and Ptch1-LacZ (22) embryos, respectively (Supplemental Figure 4 , A-F). These results suggest that SHH signaling and canonical WNT signaling regulate complementary territories during proper craniofacial morphogenesis and patterning.
Canonical WNT signaling is inhibited by SHH during frontonasal development. To further investigate the relationship between SHH and canonical WNT activity during craniofacial morphogenesis, we crossed each mutant to TOPgal mice and used LacZ expression as a read out of canonical WNT signaling. At E10.0, Hhat creface embryos expressed LacZ in the LNPs ( Figure 5D , red arrowhead), while embryos of the other genotypes did not ( Figure 5 , A-C). At E10.5, a considerable reduction in LacZ expression was detected in Ptch1 wiggable embryos ( Figure 5G ) as well as in Hhat creface Ptch1 wiggable embryos ( Figure 5F ) compared with that in control embryos ( Figure 5E ). In contrast, Hhat creface embryos showed expanded WNT activity in the LNPs ( Figure 5H ). By E11.0, the stage when the LNP and MNP fuse, strong LacZ activity could be observed at the lambdoidal junction in control embryos ( Figure 5I , red arrowhead), while Hhat creface Ptch1 wiggable embryos lacked activity in the same territory ( Figure 5J , red arrowhead). Furthermore, histological sections clearly indicated that LacZ expression in Hhat creface Ptch1 wiggable embryos ( Figure 5N , red arrowhead) was considerably reduced, especially in the olfactory epithelia, compared with that in control embryos ( Figure 5M , red arrowhead). These finding are consistent with the results from our RNA-seq analysis (Supplemental Figure 3 , D-I) confirming the spatial reduction in canonical WNT signaling. We also performed whole embryo culture using TOPgal embryos in the presence of a SHH signaling activator (purmorphamine). As expected, embryos cultured with purmorphamine showed a considerable reduction in WNT activity (LacZ) in the lambdoidal region (Supplemental Figure 5B ) compared with that in DMSO-treated embryos (Supplemental Figure 5A ). These results clearly indicate that SHH signaling restricts canonical WNT signaling during frontonasal development.
Canonical WNT inhibitor activity is modulated by SHH signaling. Since canonical WNT signaling is restricted by SHH signaling, we hypothesized that this may occur via activation of WNT inhibitors. From our RNA-seq data, we speculated that Vax1 and Sfrps might be modified by altered SHH signaling. To test our hypothesis, we performed in situ hybridization for those genes in our mutants ( Figure 6 ). Interestingly, the Vax1 expression domain was shifted distally in the nasal epithelia of Hhat creface Ptch1 wiggable embryos (Figure 6B ) compared with that of control embryos ( Figure 6A ). Similar to Vax1, the expression pattern of Sfrp1 was also changed in compound mutant embryos ( isks), exhibited elevated expression in Hhat creface Ptch1 wiggable embryos ( Figure 6 , J and N, asterisks). These results suggest that during craniofacial morphogenesis SHH signaling and its intersection with WNT signaling can be modulated by the distinct expression of individual WNT inhibitors in the facial processes.
Reduced canonical WNT signaling affects p63/IRF6 activity at the lambdoidal junction. TP63 is a member of the TP63 family of genes, and mutations in TP63 are known to be responsible for causing CL/P in mice and humans with certain syndromic diseases (24, 25) . Recently, several studies have shown that the p63/IRF6 signaling pathway plays critical roles in palatal growth and fusion (16, 17) . Furthermore, canonical WNT signaling functions upstream of this signaling cascade (15) . We therefore hypothesized that SHH signaling-associated cleft lip occurred via disruption of WNT-mediated p63/IRF6 signaling. Via in situ hybridization, we found p63/ IRF6 signaling noticeably inhibited at the lambdoidal junction in cells (CNCs) play critical roles in producing cartilage, bone, and connective tissues as well as regulating facial patterning (26) (27) (28) . SHH signaling has been shown to be a critical regulator of CNC development (29) . Hence, we assessed the formation and patterning of CNCs via in situ hybridization using Crabp1, Snail1, and Tfap2a as general markers of CNCs. Both Crabp1 and Snail1 showed equivalent expression patterns in the FNPs among all genotypes (Supplemental Figure 7) . However, the activity of Tfap2a, which is a transcription factor that directly binds to the Irf6 promoter (30) , was diminished in the FNPs in Ptch1 wiggable embryos ( Figure 7K and Supplemental Figure 6K ). Additionally, Tfap2a expression was noticeably reduced in Hhat creface Ptch1 wiggable embryos ( Figure 7J and Supplemental Figure 6J ) compared with that in controls ( Figure  7I and Supplemental Figure 6I ). We confirmed that TFAP2A protein is expressed in the epithelial seam in association with diminished ECAD in E11.5 control embryos (Supplemental Figure 6M) . Interestingly, TFAP2A activity in the epithelial seams of Ptch1 wiggable and Hhat creface Ptch1 wiggable mouse embryos was considerably reduced, correlating with persistent ECAD activity (Supplemental Figure 6,  N and O) . These results strongly suggest that altered or expanded SHH signaling during craniofacial development can affect the expression of Tfap2a in CNCs and TFAP2A in epithelial seam cells, which directly modifies IRF6 activity and contributes to epithelial seam persistence in the pathogenesis of cleft lip (Figure 8 ).
Discussion

Disruption of the SHH signaling gradient during craniofacial development results in CL/P via persistence of epithelial cells between facial processes.
Disruption of SHH signaling is associated with craniofacial defects, such as holoprosencephaly (loss of function) and nevoid basal cell carcinoma syndrome (gain of function) (31) . The fact that both of these disorders present with CL/P highlights the indispensable role of SHH signaling during FNP growth and fusion (8, 32) . We recently reported 2 novel mouse lines, both of which exhibit craniofacial defects caused by either reduced (Hhat creface ) (18) (Figure 1, B and E) . There are several studies that have described secondary cleft palate via diminished or elevated SHH signaling (9, 10, 33, 34) . However, the mechanisms underpinning the pathogenesis of cleft lip arising from altered SHH signaling are still poorly understood. Detailed observations of the developing face of Hhat creface Ptch1 wiggable embryos revealed hypoplastic nasal process development at E11.0, leading to pathogenesis of a cleft between the MNPs and LNPs at E11.5, which suggests that growth as well as fusion of these processes was impaired (Figure 2, F, J, and N) . It is well known that during nasal process fusion epithelial cells need to be removed in order to form a mesenchymal bridge, which is critical for a rigid connection in the developing lip and primary palate (3). From histological sections of the lambdoidal region, we discovered that Hhat creface Ptch1 wiggable embryos lacked the ability to remove ECAD-positive epithelial cells from the tip of developing processes ( Figure 3 , F and L). Furthermore, Hhat creface Ptch1 wiggable embryos showed reduced epithelial cell death ( Figure 3F , white arrow) and increased epithelial proliferation in association with the persistence of ECAD-labeled epithelia (Figure 3, L and O) . Although the ratio of cell death to total epithelial seam cells did not show a statistically significant difference between control and Hhat creface Ptch1 wiggable embryos (Figure 3P) , we postulate that the reduction of cell death in Hhat creface Ptch1 wiggable embryos affects the balance between cell proliferation and cell death, resulting in a persistent epithelial seam. Our work is consistent with other studies showing the persistence of epithelial cells as a consequence of decreased cell death or increased proliferation in association with CL/P (13-15, 35, 36) .
Precise levels and distribution of SHH signaling are necessary for craniofacial development. In order to assess how SHH signaling was affected in each mutant, we performed in situ hybridization for Ptch1 and Gli1, since they are direct targets of the SHH signaling cascade. During normal craniofacial development, Ptch1 and Gli1 were highly expressed in midline facial fissures and formed a gradient toward the lateral side of the face with no expression in the LNPs (Figure 4 , I and M). Expression of both Ptch1 and Gli1 was noticeably upregulated in the FNPs and expanded toward the LNPs in Ptch1 wiggable embryos (Figure 4, K and O) . The Ptch1 wiggable mutation causes a C-terminal truncation of PTCH1 protein, which is one of the key receptors of SHH. It is well known that the C-terminal intracellular domain of PTCH1 is responsible for suppressing smoothened activity by forming heterodimers in the absence of HH ligands (37) . These results clearly explain the reason that SHH signaling is overactivated in Ptch1 wiggable embryos in the absence of SHH ligand.
In contrast, Hhat creface embryos showed noticeably reduced SHH signaling during facial development (Figure 4, L and P) . This is because Hhat creface embryos are unable to palmitoylate SHH, which diminishes its capacity for diffusion and limits the SHH signaling gradient activity (18, 20, 21 ). Our results demonstrate that facial development can be partially restored in double-homozygous embryos (Figure 2 ). The total amount of Ptch1 and Gli1 expression in the maxillary complex of Hhat creface Ptch1 wiggable embryos was restored (Supplemental Figure 3 , B and C); however, their domain of activity revealed persistent expression in the LNPs, suggesting that the distribution of SHH signaling was still affected (Figure 4, J and N) . These results clearly demonstrate that craniofacial morphology is altered in association with the strength and pattern of Shh signaling.
Interaction of SHH and canonical WNT signaling during craniofacial development. Similar to SHH signaling, canonical WNT signaling is also well known to be a critical regulator of craniofacial development (38) . Previous reports have shown that reduced canonical WNT signaling through deletion of Wnt9b or Lrp6 during craniofacial development leads to facial deformity, including CL/P, in mice (13, 14) . Furthermore, a strong correlation between ectodermal canonical WNT signaling and nasal process growth has been reported (39) . From our observations of the patterns of SHH signaling (Ptch1-LacZ) and canonical WNT signaling (TOPgal) during craniofacial development, we found that those 2 signaling pathways complement each other during facial development (Supplemental Figure 4) . Furthermore, our RNA-seq data revealed that some canonical WNT signaling genes, such as Axin2 and Tcf4, are inversely expressed relative to Gli1 and Ptch1, which are targets of SHH signaling (Supplemental Figure 3) . These findings led us to hypothesize that SHH signaling represses canonical WNT signaling in order to generate defined facial compartments during craniofacial development. By crossing all mutants to TOPgal mice and assessing LacZ expression, we observed enhanced canonical WNT signaling in the growing LNPs of Hhat creface embryos, which exhibited reduced SHH signaling from E10.0 to E10.5 ( Figure 5 , D and H). Conversely, attenuated canonical WNT signaling was observed in Ptch1 wiggable and Hhat creface Ptch1 wiggable embryos in concert with expanded SHH signaling (Figure 5, F and G) . Importantly, at E11.0, when the MNP and LNP begin to fuse, the lambdoidal region expressed high levels of Wnt activity ( Figure 5I ). However, this activity was considerably reduced in Hhat creface Ptch1 wiggable embryos ( Figure 5J ). This reduction of canonical WNT signaling in the lambdoidal region is also observed in other mice in association with cleft lip (13, 14, 40) . Consistent with these observations, we could also reproduce this phenotype by culturing whole embryos in the presence of a SHH signaling agonist (Supplemental Figure 5) . These results clearly show that SHH signaling inhibits canonical WNT signaling during the process of normal lip fusion.
Canonical WNT inhibitory gene activity is altered by modulating SHH signaling. Since there was a clear inhibition of canonical WNT activity by increased SHH activity during craniofacial development, we explored a role for canonical WNT inhibitory genes in this process. Numerous canonical WNT inhibitory genes have been reported (41) , and 2 classes of secreted factor exist. One is the dickkopf (Dkk) class and another is the secreted frizzled-related (Sfrp) class (42) . We interrogated our RNA-seq data in combination with the literature to identify factors, which were activated by enhanced SHH signaling. As a result, we focused on Vax1 and Sfrp family genes. Recent studies reported significant genetic associations between VAX1 mutations and CL/P in humans (43) (44) (45) . Furthermore, Vax1-null mice display cleft palate (46) . Vax2 has been shown to be activated by SHH signaling (47) , and Vax1, together with Vax2, regulate a dominant-negative truncated transcription factor, Tcf7l2, to antagonize canonical WNT signaling (48) . In the present study, we observed altered Vax1 expression in Hhat creface Ptch1 wiggable embryos, particularly in the MNP close to the region in which process fusion takes place ( Figure 6B ).
Sfrp1 and Sfrp2 double-null mice display craniofacial deformity, illustrating their important roles during craniofacial development (49, 50) . Sfrp1 transcription has been shown to be activated by SHH signaling during retinal development (51) , and Sfrp2 is activated by SHH and plays a role in restricting canonical WNT signaling during neural tube pattering (52) . In the present study, we found altered Sfrp1 expression in the vicinity of the lambdoidal region in Hhat creface Ptch1 wiggable embryos similar to that of Vax1 ( Figure 6F ). Sfrp2 and Frzb showed increased activity in the MNPs of Hhat creface Ptch1 wiggable embryos ( Figure 6, J and N) . These results clearly demonstrate that diminished canonical WNT signaling in the lambdoidal junction in Hhat creface Ptch1 wiggable embryos correlates with altered or increased expression of canonical WNT inhibitory genes mediated by SHH signaling. We identified GLI2 and GLI3 consensus binding sequences in potential regulatory regions of Collectively, our results demonstrate a novel mechanism whereby SHH signaling modulates WNT signaling and TFAP2A expression via a p63/IRF6 cascade during facial process growth, morphogenesis, and fusion ( Figure 8 ). Disruption of any component can result in cleft lip/palate, highlighting the signaling complexity that is required for normal nasal process growth and fusion.
Methods
Mouse lines. Ptch1 wiggable mice were generated through N-ethyl-N-nitrosourea mutagenesis in our lab (19) . Hhat creface , TOPgal, and Ptch1-LacZ mice were maintained as described previously (18, 22, 23) . For embryonic staging, the morning of vaginal plug identification was defined as E0.5. We designated embryos carrying homozygous mutations as Hhat creface or Ptch1 wiggable , respectively, and Hhat creface Ptch1 wiggable as double-homozygous mice. Control mice described in the present study were either wild-type or heterozygous littermates.
Skeletal preparations. Embryos were collected at E16.5. Cartilage and bone were visualized by staining with Alizarin red and Alcian blue as described previously (18) .
Whole-mount nuclear fluorescent imaging. For analyzing facial morphological structure, we fixed the embryos in 4% PFA overnight at 4°C. Fixed embryos were washed several times in PBS and stained directly with DAPI (Sigma-Aldrich) (1:1,000) in PBS overnight at 4°C and visualized and photographed as previously described (62) .
Immunohistochemistry and cell death detection. Frozen sections (10-μm thick) were mounted on adhesive slides. The slides were washed in TBST (TBS with 0.1% Tween) and blocked with 1% BSA in TBST for 1 hour at room temperature. Slides were incubated with anti-ECAD (Abcam), anti-phospho-Histone-3 (Upstate/Millipore), anti-TFAP2A (3B5, Developmental Studies Hybridoma Bank), and anti-SSEA1 (Santa Cruz Biotechnology). Antibodies were diluted 1:500 for ECAD and phospho-Histone-3, 1:50 for TFAP2A, and 1:200 for SSEA1 overnight at 4°C and washed several times in TBST. The slides were incubated using the appropriate secondary antibody for 1 hour at room temperature and counterstained with DAPI (Sigma-Aldrich) (1:1,000) for 10 minutes at room temperature and mounted with fluorescent mounting medium (DakoCytomation). To visualize apoptosis in conjunction with ECAD immunostaining, we used the In Situ Cell Death Detection Kit Fluorescein (Roche) according to the manufacturer's instructions.
In situ hybridization. Embryos were collected as described above and fixed overnight in 4% PFA at 4°C. For whole-mount in situ hybridization (WISH), the samples were dehydrated in graded methanol and stored at -20°C until use. We rehydrated the samples and performed standard WISH protocol, which has been described before (63) . Some whole-mount embryos labelled by in situ hybridization were processed were processed through a sucrose gradient, embedded in Tissue-Tek (OCT compound, Sakura), and cut into 18-μm-thick sections for detailed observation. Section in situ hybridization was performed using 10-μm-thick frozen sections. Hybridization and color development were performed as previously reported (64) . The constructs used to produce Tp63 and Irf6 as well as Vax1 riboprobes were provided by Licia Selleri (Cornell University Medical School, New York, New York, USA) and Douglas J. Epstein (University of Pennsylvania, Philadelphia, Pennsylvania, USA), respectively.
RNA-seq. Total RNA was isolated from the E11.5 maxillary complex (encompassing MNP, LNP, and maxillary process) of embryos of each genotype (Supplemental Figure 3A) using the RNeasy Kit (Qiagen) according to the manufacturer's protocol. Sequences for each RNA sample were aligned using TopHat (v1.4.0). The reference genome and annotation files used for the alignment were from the UCSC mm9 genome and the ensemble build 65. Gene expression levels for genes are calculated using cufflinks Sfrp2 and Sfrp1, respectively. However, these sequences are not conserved among species, and it remains unknown whether these WNT inhibitory genes are direct targets of SHH signaling. Nonetheless, disrupting WNT signaling is tightly associated with the etiology of CL/P both in mice and humans (12) (13) (14) 40) . Taken together, our results highlight the indispensable role of SHH signaling in controlling canonical WNT signaling during nasal process growth and fusion via multiple WNT inhibitory genes. It is also important to note, however, the possibility that modification of SHH signaling could affect the growth of each MNP and LNP, resulting in the nasal epithelium coming into closer proximity with the highly hypoplastic bridge at the seam.
A novel pathway in the pathogenesis of cleft lip. Tp63 disruption leads to CL/P in mice (24) and is also known to be responsible for certain human syndromes that display CL/P as part of the phenotype (25, 53) . Irf6 has also been identified as a candidate gene for isolated CL/P as well as Van der Woude's syndrome (54) . Interestingly, recent studies demonstrated that p63 directly activates Irf6 transcription, allowing epithelial cells to exit the cell cycle during proper processes fusion (16, 17, 36, 55) . Furthermore, inhibiting the p63/IRF6 signaling cascade had been shown to facilitate the persistence of excessive periderm cells in the secondary palate, which is mechanistically associated with the pathogenesis of CL/P (17) . In the present study, we confirmed Irf6 downregulation in the lambdoidal region, together with attenuated Tp63 expression, in Hhat creface Ptch1 wiggable and Ptch1 wiggable embryos (Figure 7 , B, C, F, and G, and Supplemental Figure 6 , B, C, F, and G). Taken together with increased cell proliferation ( Figure 3 , K, L, and O) and stronger SSEA1 expression (Supplemental Figure 2) in the epithelium of the nasal process in Hhat creface Ptch1 wiggable embryos, our data strongly suggest that the failure of p63/IRF6-dependent cell cycle exit and periderm cell maintenance is part of the etiology and pathogenesis of cleft lip. Furthermore, a recent publication revealed a possible role for canonical WNT signaling in activating the p63/IRF6 signaling cascade (15) , which is consistent with our finding of attenuated WNT signaling in association with upregulated or expanded SHH signaling ( Figure 5 , J and K). We also investigated the influence of altering SHH signaling on neural crest cell (NCC) behavior, since many craniofacial defects, including CL/P, are known to be tightly associated with defects in NCC development (56) . Crabp1 and Snail1 are broadly expressed by CNCs (57, 58) ; however, we did not observe any significant differences in Crabp1 or Snail1 expression in the FNPs of mutant embryos compared with control embryos (Supplemental Figure 7) . Interestingly, another NCC marker, Tfap2a, which is a transcription factor well known for its critical roles during craniofacial development (59, 60) , was considerably reduced in the FNPs of Ptch1 wiggable embryos and was not restored to normal levels in Hhat creface Ptch1 wiggable embryos ( Figure 7 , J and K, and Supplemental Figure 6 , J and K). These results strongly suggest that proper SHH signaling is indispensable for NCC patterning especially via Tfap2a during normal nasal process growth and fusion. We also confirmed reduced TFAP2A activity in epithelial seam cells in Hhat creface Ptch1 wiggable and Ptch1 wiggable embryos compared with that in control embryos (Supplemental Figure 6 , M, N, and O). Interestingly, in humans, disruption of TFAP2A leads to branchio-oculo-facial syndrome, which is a congenital disease associated with CL/P (61). Moreover, disruption of the TFAP2A binding site in the promoter of IRF6 is associated with the etiology of cleft lip in humans (30) . (65, 66) with TopHat-aligned reads. We generated read counts that were mapped to exons of genes using BEDTOOLs.
β-Galactosidase staining. Hhat creface Ptch1 wiggable mice were mated to TOPgal mice (23) , and embryos were collected at E10.0, E10.5, and E11.0. All embryos were stained using the β-Galactosidase Staining Solution Kit (Chemicon/ Millipore) according to the manufacturer's instructions. Some of stained embryos were processed for 18-μm-thick frozen sections for detailed observation as described above.
Whole embryo culture with Shh agonist. TOPgal embryos were obtained from pregnant female mice at E10.0 and placed into Tyrode's solution. The decidua and Reichert's membrane were carefully removed, and a minimal incision was made in yolk sac and amnion to expose the head of the embryos. The embryos were transferred into 37°C 65% oxygen gas-supplied whole embryo culture rat serum (Harlan) with 2 mg/ml D-(+)-Glucose solution (Sigma-Aldrich) (67). 10 μM Purmorphamine (Millipore) was added to the culture media as an agonist of SHH signaling. After 24-hour culture, the embryos were collected and processed though β-galactosidase staining as described above.
Statistics. Two-tailed Student's t tests were performed for data represented in Figure 3O . P values in Supplemental Figure 3 were adjusted using the Benjamini-Hochberg procedure to control the false discovery rate. An R package, DESeq, was used to find differentially expressed genes between control and mutant samples. P values of less than 0.05 were considered significant in all experiments.
Study approval. Mice were housed in the Laboratory Animal Services Facility at the Stowers Institute for Medical Research. Welfare guidelines and procedures were performed with approval of the Stowers Institute for Medical Research IACUC.
